Diabetes mellitus and outcome after successful percutaneous coronary revascularization: The Mayo Clinic experience 1979-1998

David Hasdai, Robert A. Rizza, Diane E. Grill, Christopher G. Scott, Kirk N. Garratt, David Holmes

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To examine whether the outcome of patients after successful percutaneous coronary revascularization is influenced by diabetic status. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Materials and Methods: We analyzed the occurrence of all-cause death and death/myocardial infarction among diabetic (n = 2,155) and nondiabetic patients (n = 9,354) after successful percutaneous coronary revascularization at Mayo Clinic from October 1979 through December 1998. Results: Of the 11,509 patients who underwent percutaneous coronary revascularization during the study period, 2,155 were diabetic at the time of their index percutaneous coronary revascularization. The clinical success rate was similar for the two groups (≈87%). Among the patients with clinically successful interventions, the median (25th, 75th interquartiles) time of follow-up was 3.1 (1.1, 6.1) years for diabetic patients and 4.3 (2.0, 8.2) years for nondiabetic patients (p < 0.001). Diabetes mellitus was associated with increased adjusted risk (95% confidence interval) of death (1.73 [1.54, 1.94]) and death/infarction (1.62 [1.46, 1.79]). Conclusions: Although diabetic and nondiabetic patients had similar clinical success rates for percutaneous coronary revascularization, diabetic patients had significantly worse long-term outcomes.

Original languageEnglish (US)
Pages (from-to)132-137
Number of pages6
JournalHeartDrug
Volume1
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Percutaneous Coronary Intervention
Diabetes Mellitus
Infarction
Registries
Cause of Death
Myocardial Infarction
Confidence Intervals

Keywords

  • Angioplasty
  • Coronary artery disease
  • Diabetes mellitus
  • Prognosis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Diabetes mellitus and outcome after successful percutaneous coronary revascularization : The Mayo Clinic experience 1979-1998. / Hasdai, David; Rizza, Robert A.; Grill, Diane E.; Scott, Christopher G.; Garratt, Kirk N.; Holmes, David.

In: HeartDrug, Vol. 1, No. 3, 2001, p. 132-137.

Research output: Contribution to journalArticle

Hasdai, David ; Rizza, Robert A. ; Grill, Diane E. ; Scott, Christopher G. ; Garratt, Kirk N. ; Holmes, David. / Diabetes mellitus and outcome after successful percutaneous coronary revascularization : The Mayo Clinic experience 1979-1998. In: HeartDrug. 2001 ; Vol. 1, No. 3. pp. 132-137.
@article{cbcbdd50502e4b738415c06dfeceb4f0,
title = "Diabetes mellitus and outcome after successful percutaneous coronary revascularization: The Mayo Clinic experience 1979-1998",
abstract = "Objective: To examine whether the outcome of patients after successful percutaneous coronary revascularization is influenced by diabetic status. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Materials and Methods: We analyzed the occurrence of all-cause death and death/myocardial infarction among diabetic (n = 2,155) and nondiabetic patients (n = 9,354) after successful percutaneous coronary revascularization at Mayo Clinic from October 1979 through December 1998. Results: Of the 11,509 patients who underwent percutaneous coronary revascularization during the study period, 2,155 were diabetic at the time of their index percutaneous coronary revascularization. The clinical success rate was similar for the two groups (≈87{\%}). Among the patients with clinically successful interventions, the median (25th, 75th interquartiles) time of follow-up was 3.1 (1.1, 6.1) years for diabetic patients and 4.3 (2.0, 8.2) years for nondiabetic patients (p < 0.001). Diabetes mellitus was associated with increased adjusted risk (95{\%} confidence interval) of death (1.73 [1.54, 1.94]) and death/infarction (1.62 [1.46, 1.79]). Conclusions: Although diabetic and nondiabetic patients had similar clinical success rates for percutaneous coronary revascularization, diabetic patients had significantly worse long-term outcomes.",
keywords = "Angioplasty, Coronary artery disease, Diabetes mellitus, Prognosis",
author = "David Hasdai and Rizza, {Robert A.} and Grill, {Diane E.} and Scott, {Christopher G.} and Garratt, {Kirk N.} and David Holmes",
year = "2001",
doi = "10.1159/000048949",
language = "English (US)",
volume = "1",
pages = "132--137",
journal = "HeartDrug",
issn = "1422-9528",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Diabetes mellitus and outcome after successful percutaneous coronary revascularization

T2 - The Mayo Clinic experience 1979-1998

AU - Hasdai, David

AU - Rizza, Robert A.

AU - Grill, Diane E.

AU - Scott, Christopher G.

AU - Garratt, Kirk N.

AU - Holmes, David

PY - 2001

Y1 - 2001

N2 - Objective: To examine whether the outcome of patients after successful percutaneous coronary revascularization is influenced by diabetic status. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Materials and Methods: We analyzed the occurrence of all-cause death and death/myocardial infarction among diabetic (n = 2,155) and nondiabetic patients (n = 9,354) after successful percutaneous coronary revascularization at Mayo Clinic from October 1979 through December 1998. Results: Of the 11,509 patients who underwent percutaneous coronary revascularization during the study period, 2,155 were diabetic at the time of their index percutaneous coronary revascularization. The clinical success rate was similar for the two groups (≈87%). Among the patients with clinically successful interventions, the median (25th, 75th interquartiles) time of follow-up was 3.1 (1.1, 6.1) years for diabetic patients and 4.3 (2.0, 8.2) years for nondiabetic patients (p < 0.001). Diabetes mellitus was associated with increased adjusted risk (95% confidence interval) of death (1.73 [1.54, 1.94]) and death/infarction (1.62 [1.46, 1.79]). Conclusions: Although diabetic and nondiabetic patients had similar clinical success rates for percutaneous coronary revascularization, diabetic patients had significantly worse long-term outcomes.

AB - Objective: To examine whether the outcome of patients after successful percutaneous coronary revascularization is influenced by diabetic status. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Materials and Methods: We analyzed the occurrence of all-cause death and death/myocardial infarction among diabetic (n = 2,155) and nondiabetic patients (n = 9,354) after successful percutaneous coronary revascularization at Mayo Clinic from October 1979 through December 1998. Results: Of the 11,509 patients who underwent percutaneous coronary revascularization during the study period, 2,155 were diabetic at the time of their index percutaneous coronary revascularization. The clinical success rate was similar for the two groups (≈87%). Among the patients with clinically successful interventions, the median (25th, 75th interquartiles) time of follow-up was 3.1 (1.1, 6.1) years for diabetic patients and 4.3 (2.0, 8.2) years for nondiabetic patients (p < 0.001). Diabetes mellitus was associated with increased adjusted risk (95% confidence interval) of death (1.73 [1.54, 1.94]) and death/infarction (1.62 [1.46, 1.79]). Conclusions: Although diabetic and nondiabetic patients had similar clinical success rates for percutaneous coronary revascularization, diabetic patients had significantly worse long-term outcomes.

KW - Angioplasty

KW - Coronary artery disease

KW - Diabetes mellitus

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0034901127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034901127&partnerID=8YFLogxK

U2 - 10.1159/000048949

DO - 10.1159/000048949

M3 - Article

AN - SCOPUS:0034901127

VL - 1

SP - 132

EP - 137

JO - HeartDrug

JF - HeartDrug

SN - 1422-9528

IS - 3

ER -